Philip Yeske

Philip Yeske

Company: United Mitochondrial Disease Foundation

Job title: Science & Alliance Officer

Bio:

Philip Yeske received a bachelor’s degree in chemistry from Allegheny College and a doctorate in organic chemistry from Emory University. Prior to joining the United Mitochondrial Disease Foundation, Dr. Yeske served as President and CEO of Fluorous Technologies, a Pittsburgh-based, early-stage life sciences company. He also worked at Bayer Corporation in positions ranging from basic research to global account management and co-founded the drug discovery company MS2 Array. Dr. Yeske has been active in the mitochondrial disease community since 2004, first as a parent of an affected child, then as a trustee of the UMDF.  In 2013, he accepted the position of UMDF Science & Alliance Officer, responsible for leading the foundation’s research mission and managing all scientific and business development efforts related to improved diagnoses, development of treatments and cures, and optimized patient care.

 

Seminars:

Chair’s Closing Remarks 5:15 pm

Read more

day: Day One

Building the Mitochondrial Disease Patient Perspective, One Voice at a Time 4:45 pm

• Examine why it is important to engage patient community early in the therapeutic development process • Learn to understand burden of the disease as well as what meaningful treatments look like from the patient perspective • Explore why regulatory agencies are increasingly interested in “Voice of the Patient” in addition to traditional efficacy and…Read more

day: Day One

Chair’s Opening Remarks 8:45 am

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.